1.
Wechalekar AD, Lachmann HJ, Offer M, Hawkins PN, Gillmore JD. Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease. Haematologica [Internet]. 2008Jan.31 [cited 2026Nov.12];93(2):295-8. Available from: https://haematologica.org/article/view/4754